title: [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
authors.forename: N V
authors.initials: NV
authors.lastname: Beloborodova
authors.forename: D A
authors.initials: DA
authors.lastname: Popov
authors.forename: T Iu
authors.initials: TIu
authors.lastname: Vostrikova
authors.forename: E N
authors.initials: EN
authors.lastname: Bachinskaia
authors.forename: S T
authors.initials: ST
authors.lastname: Kuznetsova
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001372:Aza Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D004334:Drug Administration Schedule; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D000077266:Moxifloxacin; D011183:Postoperative Complications / Q000188:drug therapy* / Q000382:microbiology; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin